Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.1877
+0.0197 (11.73%)
At close: Nov 4, 2026, 4:00 PM EST
0.1849
-0.0028 (-1.49%)
After-hours: Nov 4, 2026, 7:18 PM EST

Vistagen Therapeutics Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Quarter
Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
1.480.470.30.260.24-0.020.230.180.080.20.410.280.180.180.18-0.890.310.040.360.36
Revenue Growth (YoY)
504.92%-29.49%40.98%190.48%--43.07%-34.17%-52.54%12.00%128.84%--42.92%352.19%-49.82%--12.43%-91.20%14.13%7.19%
Gross Profit
1.480.470.30.260.24-0.020.230.180.080.20.410.280.180.180.18-0.890.310.040.360.36
Selling, General & Admin
3.924.125.634.44.374.274.054.24.574.123.763.212.983.083.093.74.924.633.173.36
Research & Development
10.9113.0614.2215.9211.6810.2111.3110.227.657.444.543.854.29.346.8512.8915.1612.17.739.79
Operating Expenses
14.8217.1819.8520.3116.0514.4815.3514.4112.2211.568.37.067.1812.429.9516.620.0816.7310.913.16
Operating Income
-13.35-16.72-19.55-20.05-15.8-14.5-15.12-14.23-12.13-11.36-7.88-6.78-7-12.24-9.77-17.49-19.77-16.69-10.54-12.8
Interest Expense
-----------------0---
Interest & Investment Income
0.320.450.650.630.710.861.031.271.41.531.530.190.10.010.010.010.0100.010.01
Other Non Operating Income (Expenses)
-0-0-0.01-00.01---0.31----------
EBT Excluding Unusual Items
-13.03-16.27-18.9-19.42-15.1-13.64-14.09-12.95-10.73-9.52-6.35-6.59-6.9-12.23-9.76-17.48-19.77-16.69-10.54-12.79
Pretax Income
-13.03-16.27-18.9-19.42-15.1-13.64-14.09-12.95-10.73-9.52-6.35-6.59-6.9-12.23-9.76-17.48-19.77-16.69-10.54-12.79
Income Tax Expense
-0.01-----0.01-0--00--0.01---
Net Income
-13.03-16.27-18.9-19.42-15.1-13.64-14.09-12.96-10.73-9.52-6.35-6.59-6.9-12.23-9.76-17.48-19.78-16.69-10.54-12.79
Preferred Dividends & Other Adjustments
------------------0.210.38
Net Income to Common
-13.03-16.27-18.9-19.42-15.1-13.64-14.09-12.96-10.73-9.52-6.35-6.59-6.9-12.23-9.76-17.48-19.78-16.69-10.74-13.17
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
43424236323231313131291077777776
Shares Outstanding (Diluted)
43424236323231313131291077777776
Shares Change (YoY)
34.61%34.13%37.52%16.70%4.34%3.40%4.50%205.03%317.11%326.26%326.25%45.68%6.54%4.08%2.23%7.03%8.78%42.45%149.52%188.04%
EPS (Basic)
-0.30-0.38-0.45-0.54-0.47-0.43-0.46-0.42-0.35-0.31-0.22-0.66-0.94-1.71-1.42-2.54-2.87-2.43-1.59-2.04
EPS (Diluted)
-0.30-0.38-0.45-0.54-0.47-0.43-0.46-0.42-0.35-0.31-0.22-0.66-0.94-1.71-1.42-2.54-2.87-2.43-1.59-2.04
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-14.71-16.2-17.66-13.82-18.91-10.15-10.28-10.95-10.91-7.01-4.78-6.19-7.89-7.47-9.95-16.37-16.14-15.59-12.05-11.5
Free Cash Flow Per Share
-0.34-0.38-0.42-0.39-0.59-0.32-0.34-0.36-0.36-0.23-0.16-0.62-1.08-1.04-1.44-2.37-2.34-2.27-1.79-1.78
Gross Margin
100.00%100.00%100.00%100.00%100.00%-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-100.00%100.00%100.00%100.00%
Operating Margin
-904.34%-3595.05%-6450.83%-7772.48%-6477.05%--6461.54%-7774.32%-14441.67%-5765.99%-1918.25%-2438.85%-3953.67%-6957.99%-5437.92%--6376.36%-42912.60%-2945.01%-3575.28%
Profit Margin
-882.79%-3499.78%-6237.29%-7525.97%-6186.48%--6020.94%-7082.51%-12777.38%-4832.99%-1545.01%-2369.78%-3900.00%-6951.28%-5434.97%--6377.39%-42900.77%-3001.73%-3678.66%
Free Cash Flow Margin
-996.41%-3483.87%-5827.39%-5356.20%-7750.41%--4393.16%-5981.97%-12989.29%-3560.41%-1162.77%-2226.62%-4458.19%-4248.78%-5537.75%--5205.87%-40073.52%-3365.58%-3212.32%
EBITDA
-13.3-16.67-19.49-20-15.76-14.46-15.08-14.19-12.1-11.33-7.85-6.75-6.97-12.21-9.74-17.46-19.74-16.65-10.5-12.76
D&A For EBITDA
0.050.050.050.050.040.040.040.040.030.030.030.030.030.030.030.030.030.040.040.04
EBIT
-13.35-16.72-19.55-20.05-15.8-14.5-15.12-14.23-12.13-11.36-7.88-6.78-7-12.24-9.77-17.49-19.77-16.69-10.54-12.8
Revenue as Reported
1.480.470.30.260.24-0.230.180.080.20.410.280.180.180.18-0.890.310.040.360.36
SEC Filings: 10-K · 10-Q